Vantage Consulting Group’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-4,219
Closed -$409K 34
2024
Q2
$409K Sell
4,219
-405
-9% -$37.4K 0.3% 38
2024
Q1
$416K Sell
4,624
-577
-11% -$48.9K 0.26% 42
2023
Q4
$415K Sell
5,201
-567
-10% -$42.6K 0.28% 41
2023
Q3
$410K Sell
5,768
-673
-10% -$50.3K 0.27% 40
2023
Q2
$496K Sell
6,441
-703
-10% -$54.4K 0.29% 38
2023
Q1
$537K Buy
7,144
+539
+8% +$40.1K 0.3% 31
2022
Q4
$520K Sell
6,605
-392
-6% -$29.4K 0.31% 21
2022
Q3
$492K Buy
6,997
+326
+5% +$25.6K 0.29% 26
2022
Q2
$535K Buy
6,671
+61
+0.9% +$4.77K 0.3% 19
2022
Q1
$501K Sell
6,610
-332
-5% -$26.3K 0.2% 36
2021
Q4
$592K Buy
6,942
+215
+3% +$16.8K 0.16% 18
2021
Q3
$508K Buy
6,727
+617
+10% +$49K 0.11% 29
2021
Q2
$497K Buy
6,110
+1,406
+30% +$115K 0.09% 39
2021
Q1
$371K Buy
4,704
+1,910
+68% +$150K 0.07% 25
2020
Q4
$239K Buy
+2,794
New +$231K 0.02% 36

Other funds holding CL

Vantage Consulting Group's CL Position: Q3 2024 in Review

Vantage Consulting Group sold out of Colgate-Palmolive (CL) in Q3 2024, closing a stake of 4,219 shares — an estimated $409K sold.

Vantage Consulting Group first reported a position in CL in Q4 2020 and held it in 15 quarters. The position peaked at $592K in Q4 2021. 1,909 funds tracked by Wall St. Rank hold CL as of Q3 2024.

  • Vantage Consulting Group reported no remaining Colgate-Palmolive position as of Q3 2024 after selling out during the quarter.
  • Vantage Consulting Group sold 4,219 Colgate-Palmolive shares in Q3 2024, an estimated $409K.
  • Vantage Consulting Group first reported a position in Colgate-Palmolive in Q4 2020 and held it in 15 quarters.
  • Vantage Consulting Group's Colgate-Palmolive position peaked at $592K in Q4 2021.
  • 1,909 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2024.

Based on Vantage Consulting Group's 13F filing for Q3 2024, filed 14 Nov 2024.